ConductScience.org, home

Paper3966974

Misonidazole protects mouse tumour and normal tissues from the toxicity of oral CCNU.

Lee FY and 1 other. Br J Cancer, 1985. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Misonidazole protects mouse tumour and normal tissues from the toxicity of oral CCNU. Papers, record 3966974. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3966974

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Misonidazole protects mouse tumour and normal tissues from the toxicity of oral CCNU.
PubMed
Journal
Br J Cancer
PubMed
Year
1985
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.23
iCite
Revised in PubMed
2019-05-15
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lee FYF Y
2Workman PP

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FibrosarcomaMajor topic
LomustineMajor topic
MisonidazoleMajor topic
NitroimidazolesMajor topic
Administration, Oral
Animals
Drug Interactions
Injections, Intraperitoneal
Lethal Dose 50
Male
Mice
Mice, Inbred C3H

Source PubMed

Download CSV of topics

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17459221In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: cyclophosphamide and BCNU.Br J Cancer1980https://conductscience.org/library/papers/7459221PubMed
25527023Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules.Cancer Chemother Rep1970https://conductscience.org/library/papers/5527023PubMed
36480457A phase I study of the combination of benznidazole and CCNU in man.Int J Radiat Oncol Biol Phys1984https://conductscience.org/library/papers/6480457PubMed
4145865Comparison of the properties of metabolites of CCNU.Biochem Pharmacol1977https://conductscience.org/library/papers/145865PubMed
5528273The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors--I. Adriamycin.Int J Radiat Oncol Biol Phys1979https://conductscience.org/library/papers/528273PubMed
67225287In vivo combination of misonidazole and the chemotherapeutic agent CCNU.Br J Cancer1981https://conductscience.org/library/papers/7225287PubMed
76895696A comparison of adriamycin and mAMSA in vitro: cell lethality and SCE studies.Br J Cancer1981https://conductscience.org/library/papers/6895696PubMed
86460517Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.Br J Cancer1982https://conductscience.org/library/papers/6460517PubMed
97073947Growth delay in small EMT6 spheroids induced by cytotoxic drugs and its modification by misonidazole pretreatment under hypoxic conditions.Br J Cancer1982https://conductscience.org/library/papers/7073947PubMed
107081141Misonidazole enhancement of the action of BCNU and melphalan against human melanoma xenografts.Am J Clin Oncol1982https://conductscience.org/library/papers/7081141PubMed
117201845Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain.Br J Cancer1982https://conductscience.org/library/papers/7201845PubMed
127107378Enhancement of chemotherapy agents.Int J Radiat Oncol Biol Phys1982https://conductscience.org/library/papers/7107378PubMed
137150475Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNU.Br J Cancer1982https://conductscience.org/library/papers/7150475PubMed
146838633Drug metabolism and chemosensitization. Nitroimidazoles as inhibitors of drug metabolism.Biochem Pharmacol1983https://conductscience.org/library/papers/6838633PubMed
156849803Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice.Br J Cancer1983https://conductscience.org/library/papers/6849803PubMed
166883348Phase I trial of intravenous L-phenylalanine mustard plus the sensitizer misonidazole.Cancer Res1983https://conductscience.org/library/papers/6883348PubMed
176615699The effect of radiosensitizers on the pharmacokinetics of melphalan and cyclophosphamide in the mouse.Br J Cancer1983https://conductscience.org/library/papers/6615699PubMed
186722006Misonidazole and CCNU: further evidence for a pharmacokinetic mechanism of chemosensitization and therapeutic gain.Br J Cancer1984https://conductscience.org/library/papers/6722006PubMed
196384159Modification of chemotherapy by nitroimidazoles.Int J Radiat Oncol Biol Phys1984https://conductscience.org/library/papers/6384159PubMed
207460192Dose-dependence and related studies on the pharmacokinetics of misonidazole and desmethylmisonidazole in mice.Cancer Chemother Pharmacol1980https://conductscience.org/library/papers/7460192PubMed

Download CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn Papers
3948306Pharmacokinetics in experimental and clinical chemotherapy.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3948306

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3966974

GET https://conductscience.org/api/papers/v1/3966974/authors